Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a pharmaceutical company based in China. They specialize in manufacturing a wide range of pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies. With a high risk rating score of 33.5, the company operates under different segments such as Great Southern TCM, Great Health, and Great Commerce. They generate most of their revenue from the Great Commerce segment. The company prioritizes environment, sustainability, and governance (ESG) practices in their operations.